Botulinum Toxin’s Efficacy for Post-Prostatectomy OAB Varies by Subtype
Long-term post-prostatectomy urinary incontinence affects 3% to 10% of patients.
Prostate Cancer
PSA Screening Recommendation Tied to Decrease in Prostate Cancer-Specific Survival
The 3-year prostate cancer-specific survival decreased significantly for insured patients.
Prostate Cancer Observation Varies With MRI, Genomic Testing Availability
Increasing adoption of prostate MRI and genomic testing may reduce overtreatment of prostate cancer, according to investigators.
Pembrolizumab and Olaparib Combination Therapy Shows Antitumor Activity and Acceptable Safety for Pretreated mCRPC
The nonrandomized, multicenter, multicohort, open-label, phase 1b/2 KEYNOTE-365 trial evaluated the safety, tolerability, and efficacy of pembrolizumab combination therapy in men with mCRPC.
Video May Aid in Precision Medicine for Prostate Cancer
In a study of men with prostate cancer or a family history of the disease, a higher proportion of men opted to view an educational video over personal genetic counseling prior to genetic testing.
Androgen Signaling Inhibitors Appear More Effective in Luminal Metastatic Castration-Resistant Prostate Cancer
Patients with basal tumors did not derive a significant survival benefit from androgen signaling inhibitors.
Castration Resistance-Free Survival With Relugolix vs Leuprolide in Advanced Prostate Cancer
CRFS after relugolix was not significantly different compared with leuprolide in men with advanced prostate cancer and metastatic disease.
Study: 68Ga-PSMA-11 PET May Miss Pelvic Nodal Metastasis in Prostate Cancer
68Ga-PSMA-11 PET scans have a 40% sensitivity for detecting pelvic nodal metastasis in men with intermediate- or high-risk prostate cancer, data show.
Prostate Cancer Delays Kidney Transplantation, Ups Death Risk in Dialysis
Understanding how prostate cancer affects death after kidney failure is important for appropriate management and guideline development.
Surgery vs Radiation May Lower Risk of Death From High-Risk Prostate Cancer
In a large retrospective study, radical prostatectomy was significantly associated with a survival advantage among men with high-risk prostate cancer compared with external beam radiation therapy.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...